irinotecan has been researched along with Neoplasms, Nervous System in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheung, NK; Kramer, K; Kushner, BH; Modak, S | 1 |
| Bigner, DD; Dolan, ME; Elion, GB; Friedman, HS; Houghton, PJ; Johnson, SP; Keir, S; Patel, VJ; Pegg, AE | 1 |
2 other study(ies) available for irinotecan and Neoplasms, Nervous System
| Article | Year |
|---|---|
Five-day courses of irinotecan as palliative therapy for patients with neuroblastoma.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Camptothecin; Child; Child, Preschool; Female; Humans; Infusions, Intravenous; Irinotecan; Male; Nervous System Neoplasms; Neuroblastoma; Palliative Care; Quality of Life; Retrospective Studies; Treatment Outcome | 2005 |
Schedule-dependent activity of temozolomide plus CPT-11 against a human central nervous system tumor-derived xenograft.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Dacarbazine; Female; Humans; Irinotecan; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Nervous System Neoplasms; Temozolomide; Time Factors; Tumor Cells, Cultured | 2000 |